184 related articles for article (PubMed ID: 10096590)
1. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test.
Cho MK; Sankar P; Wolpe PR; Godmilow L
Am J Med Genet; 1999 Mar; 83(3):157-63. PubMed ID: 10096590
[TBL] [Abstract][Full Text] [Related]
2. Physicians' Awareness and Utilization of Genetic Services in Texas.
Diamonstein C; Stevens B; Shahrukh Hashmi S; Refuerzo J; Sullivan C; Hoskovec J
J Genet Couns; 2018 Aug; 27(4):968-977. PubMed ID: 29280038
[TBL] [Abstract][Full Text] [Related]
3. Genetic counseling for BRCA1/BRCA2 testing.
Schneider KA
Genet Test; 1997; 1(2):91-8. PubMed ID: 10464632
[TBL] [Abstract][Full Text] [Related]
4. Physicians' experiences with BRCA1/2 testing in community settings.
Keating NL; Stoeckert KA; Regan MM; DiGianni L; Garber JE
J Clin Oncol; 2008 Dec; 26(35):5789-96. PubMed ID: 19001322
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
6. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.
Metcalfe KA; Liede A; Hoodfar E; Scott A; Foulkes WD; Narod SA
J Med Genet; 2000 Nov; 37(11):866-74. PubMed ID: 11073541
[TBL] [Abstract][Full Text] [Related]
8. Attitudes and practice of genetic counselors regarding anonymous testing for BRCA1/2.
Ader T; Susswein LR; Callanan NP; Evans JP
J Genet Couns; 2009 Dec; 18(6):606-17. PubMed ID: 19798553
[TBL] [Abstract][Full Text] [Related]
9. An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.
Lynch HT; Watson P; Tinley S; Snyder C; Durham C; Lynch J; Kirnarsky Y; Serova O; Lenoir G; Lerman C; Narod SA
Cancer Genet Cytogenet; 1999 Mar; 109(2):91-8. PubMed ID: 10087939
[TBL] [Abstract][Full Text] [Related]
10. Early adoption of BRCA1/2 testing: who and why.
Armstrong K; Weiner J; Weber B; Asch DA
Genet Med; 2003; 5(2):92-8. PubMed ID: 12644778
[TBL] [Abstract][Full Text] [Related]
11. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer EJ; Verhoog LC; Brekelmans CT; Seynaeve C; Tilanus-Linthorst MM; Wagner A; Dukel L; Devilee P; van den Ouweland AM; van Geel AN; Klijn JG
Lancet; 2000 Jun; 355(9220):2015-20. PubMed ID: 10885351
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
13. Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing.
Durfy SJ; Buchanan TE; Burke W
Am J Med Genet; 1998 Jan; 75(1):82-7. PubMed ID: 9450863
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing: a challenge to the preventive paradigm.
Reinhard JD
HMO Pract; 1996 Jun; 10(2):50-2. PubMed ID: 10161347
[No Abstract] [Full Text] [Related]
15. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
16. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
Nilsson MP; Nilsson ED; Borg Å; Brandberg Y; Silfverberg B; Loman N
Breast Cancer Res Treat; 2019 Jan; 173(2):313-318. PubMed ID: 30311024
[TBL] [Abstract][Full Text] [Related]
17. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
[TBL] [Abstract][Full Text] [Related]
18. Impact of a genetic counseling requirement prior to genetic testing.
Stenehjem DD; Au T; Sainski AM; Bauer H; Brown K; Lancaster J; Stevens V; Brixner DI
BMC Health Serv Res; 2018 Mar; 18(1):165. PubMed ID: 29514700
[TBL] [Abstract][Full Text] [Related]
19. Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.
White DB; Bonham VL; Jenkins J; Stevens N; McBride CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):2980-6. PubMed ID: 18990739
[TBL] [Abstract][Full Text] [Related]
20. Physicians' experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece.
Fountzilas E; Apostolou P; Vasiliadis AV; Aivazi D; Saloustros E; Fostira F
Fam Cancer; 2022 Oct; 21(4):479-487. PubMed ID: 35067824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
